Patrick Thomas Ellinor II
CIK: 0002137699
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EDIT
Editas Medicine, Inc.
Director
Discretionary Trading P&L
Holdings
About Ellinor Patrick Thomas II
Ellinor Patrick Thomas II (SEC CIK 0002137699) files insider reports with the SEC as Director of Editas Medicine, Inc. (EDIT).
Signal8 holds 2 ownership filings by Ellinor Patrick Thomas II (1 Form 3, 1 Form 4), filed on Aug 7, 2026. Those filings report 1 transaction, the latest on Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ellinor Patrick Thomas II's filings is in CAMBRIDGE, MA.
Recent filings by Ellinor Patrick Thomas II
- Aug 6, 2026: Grant or award of EDIT derivative securities (Form 4, code A).
Other insiders filing for Editas Medicine, Inc. (EDIT)
- Ory Daniel Scott, EVP, Chief Medical Officer
- Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER
- Parison Amy, SVP, Chief Financial Officer
- O'Neill Gilmore Neil, CEO
- Connaughton Bernadette, Director
- Hopfield Jessica, Director